Rho(D) immune globulin (RhIG) is a medication used to prevent Rh isoimmunization in mothers who are Rh negative and to treat idiopathic thrombocytopenic purpura (ITP) in people who are Rh positive. It is often given both during and following pregnancy. It may also be used when Rh negative people are given Rh positive blood. It is given by injection into muscle or a vein. A single dose lasts 2 to 4 weeks.
This report contains market size and forecasts of Rho(D) Immune Globulin in global, including the following market information:
Global Rho(D) Immune Globulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Rho(D) Immune Globulin Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Rho(D) Immune Globulin companies in 2021 (%)
The global Rho(D) Immune Globulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5 ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rho(D) Immune Globulin include CSL Behring, Grіfоlѕ, Bayer, Kedrion Biopharma and Saol Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rho(D) Immune Globulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rho(D) Immune Globulin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rho(D) Immune Globulin Market Segment Percentages, by Type, 2021 (%)
5 ml
10 ml
Global Rho(D) Immune Globulin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rho(D) Immune Globulin Market Segment Percentages, by Application, 2021 (%)
Government Institution
Private Sector
Others
Global Rho(D) Immune Globulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Rho(D) Immune Globulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Rho(D) Immune Globulin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Rho(D) Immune Globulin revenues share in global market, 2021 (%)
Key companies Rho(D) Immune Globulin sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Rho(D) Immune Globulin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
CSL Behring
Grіfоlѕ
Bayer
Kedrion Biopharma
Saol Therapeutics